Integer Holdings Revenue 2011-2025 | ITGR
Integer Holdings revenue from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Integer Holdings Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $1,717 |
| 2023 | $1,556 |
| 2022 | $1,331 |
| 2021 | $1,221 |
| 2020 | $1,073 |
| 2019 | $1,258 |
| 2018 | $1,215 |
| 2017 | $1,136 |
| 2016 | $1,076 |
| 2015 | $800 |
| 2014 | $688 |
| 2013 | $664 |
| 2012 | $646 |
| 2011 | $569 |
| 2010 | $533 |
|
Integer Holdings Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $468 |
| 2025-06-30 | $476 |
| 2025-03-31 | $437 |
| 2024-12-31 | $449 |
| 2024-09-30 | $431 |
| 2024-06-30 | $428 |
| 2024-03-31 | $408 |
| 2023-12-31 | $380 |
| 2023-09-30 | $397 |
| 2023-06-30 | $400 |
| 2023-03-31 | $379 |
| 2022-12-31 | $328 |
| 2022-09-30 | $343 |
| 2022-06-30 | $350 |
| 2022-03-31 | $311 |
| 2021-12-31 | $313 |
| 2021-09-30 | $306 |
| 2021-06-30 | $312 |
| 2021-03-31 | $290 |
| 2020-12-31 | $269 |
| 2020-09-30 | $236 |
| 2020-06-30 | $240 |
| 2020-03-31 | $328 |
| 2019-12-31 | $326 |
| 2019-09-30 | $304 |
| 2019-06-30 | $314 |
| 2019-03-31 | $315 |
| 2018-12-31 | $303 |
| 2018-09-30 | $305 |
| 2018-06-30 | $314 |
| 2018-03-31 | $292 |
| 2017-12-31 | $224 |
| 2017-09-30 | $286 |
| 2017-06-30 | $281 |
| 2017-03-31 | $345 |
| 2016-12-31 | $48 |
| 2016-09-30 | $347 |
| 2016-06-30 | $348 |
| 2016-03-31 | $332 |
| 2015-12-31 | $318 |
| 2015-09-30 | $147 |
| 2015-06-30 | $175 |
| 2015-03-31 | $161 |
| 2014-12-31 | $170 |
| 2014-09-30 | $172 |
| 2014-06-30 | $172 |
| 2014-03-31 | $174 |
| 2013-12-31 | $177 |
| 2013-09-30 | $168 |
| 2013-06-30 | $171 |
| 2013-03-31 | $148 |
| 2012-12-31 | $159 |
| 2012-09-30 | $161 |
| 2012-06-30 | $167 |
| 2012-03-31 | $159 |
| 2011-12-31 | $142 |
| 2011-09-30 | $132 |
| 2011-06-30 | $147 |
| 2011-03-31 | $149 |
| 2010-12-31 | $133 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.447B | $1.717B |
| Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.194B | 25.57 |
| Intuitive Surgical (ISRG) | United States | $206.246B | 80.69 |
| IDEXX Laboratories (IDXX) | United States | $57.022B | 56.63 |
| Edwards Lifesciences (EW) | United States | $50.016B | 33.54 |
| Alcon (ALC) | Switzerland | $39.820B | 26.91 |
| IQVIA Holdings (IQV) | United States | $38.462B | 21.45 |
| Mettler-Toledo (MTD) | United States | $28.903B | 33.82 |
| STERIS (STE) | Ireland | $25.840B | 26.67 |
| DexCom (DXCM) | United States | $25.542B | 35.21 |
| Waters (WAT) | United States | $23.505B | 31.09 |
| Hologic (HOLX) | United States | $16.711B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.990B | 0.00 |
| Globus Medical (GMED) | United States | $12.193B | 25.59 |
| Penumbra (PEN) | United States | $11.774B | 82.83 |
| Masimo (MASI) | United States | $7.610B | 24.39 |
| Glaukos (GKOS) | United States | $6.232B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.810B | 18.46 |
| Teleflex (TFX) | United States | $5.325B | 8.49 |
| TransMedics (TMDX) | United States | $4.665B | 55.27 |
| Veracyte (VCYT) | United States | $3.526B | 40.19 |
| LivaNova (LIVN) | United Kingdom | $3.460B | 18.69 |
| Alphatec Holdings (ATEC) | United States | $3.186B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.210B | 20.67 |
| Artivion (AORT) | United States | $2.112B | 96.93 |
| PROCEPT BioRobotics (PRCT) | United States | $2.004B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.740B | 15.19 |
| UFP Technologies (UFPT) | United States | $1.675B | 22.11 |
| AxoGen (AXGN) | United States | $1.537B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.418B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.293B | 0.00 |
| IRadimed (IRMD) | United States | $1.203B | 57.32 |
| Integra LifeSciences Holdings (IART) | United States | $1.031B | 5.59 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.899B | 0.00 |
| SiBone (SIBN) | United States | $0.854B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.630B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.623B | 36.25 |
| AngioDynamics (ANGO) | United States | $0.555B | 0.00 |
| NeuroPace (NPCE) | United States | $0.546B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.523B | 10.43 |
| RxSight (RXST) | United States | $0.519B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.462B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.429B | 11.83 |
| Sight Sciences (SGHT) | United States | $0.426B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.345B | 57.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.285B | 2.13 |
| Spectral Diagnostics (EDTXF) | Canada | $0.270B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.238B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| CVRx (CVRX) | United States | $0.237B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.188B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.175B | 0.00 |
| Solana (HSDT) | United States | $0.159B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.159B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.142B | 0.00 |
| LENSAR (LNSR) | United States | $0.134B | 0.00 |
| Accuray (ARAY) | United States | $0.112B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.109B | 0.00 |
| Hyperfine (HYPR) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Neuronetics (STIM) | United States | $0.092B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.090B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.064B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.020B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.015B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.18 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |